Almost two years into the pandemic, the scientific and healthcare communities continue to learn a great deal regarding COVID-19, the disease produced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Broad variability during acute COVID-19 infection is seen, ranging from asymptomatic presentation to death. The vast majority of individuals who develop COVID-19 return to their pre-COVID-19 baseline within several weeks. However, a portion of patients will develop a post-COVID-19 syndrome of persistent cognitive, somatic, and behavioral symptoms. This syndrome, designated as post-acute sequelae of SARS-CoV-2 infection, is more commonly known as long COVID. The objectives of this paper are to inform psychologists regarding our current understanding of the underlying pathophysiology of COVID-19, review criteria for range of severity during acute illness, present clinical manifestations of long haul phenomena, and discuss the emerging literature base of evidence-based treatment and management approaches.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- healthcare
- liver failure
- end stage renal disease
- case report
- respiratory failure
- drug induced
- copy number
- gene expression
- ejection fraction
- peritoneal dialysis
- smoking cessation
- physical activity
- social media
- combination therapy
- acute respiratory distress syndrome
- preterm birth
- hepatitis b virus
- extracorporeal membrane oxygenation